Survival Stats for Pancreas Cancer
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer | Clinical Cancer Research
Prognostic factors in patients with pancreatic cancer
Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score) - Radiotherapy and Oncology
Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Overall survival in 379 patients with pancreatic cancer was... | Download Scientific Diagram
Overall survival curves in patients with advanced pancreatic cancer... | Download Scientific Diagram
Prognostic Factors of Unresectable Pancreatic Cancer Treated with Nafamostat Mesilate Combined with Gemcitabine Chemotherapy | Anticancer Research
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer -
Metastatic Pancreatic Cancer | ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
Conditional Survival in Patients with Advanced Pancreatic Cancer | Insight Medical Publishing
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study | BMC Cancer | Full Text
Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer | Insight Medical Publishing
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial - The Lancet Oncology
Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III? - ScienceDirect
Post-surgical overall survival of pancreatic cancer according to c-fos expression in cancer tissues (Log-rank test; P = 0.020).
Figure 1 from Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? | Semantic Scholar
Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy
![Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/4893/1/fig-1-full.png "Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]")
Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China [PeerJ]
pancreas cancer
Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis
Prognosis of distal pancreatic cancers controlled by stage
Overall survival of patients with metastatic pancreatic cancer... | Download Scientific Diagram
Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study | BMC Medicine | Full
Survival Prediction for Romanian Patients with Pancreatic Cancer
